In hot water with angry parents, is Johnson & Johnson’s response too tepid?

A safe-cosmetics campaign says the company has lagged in removing alleged carcinogens from its baby shampoo. Is Johnson & Johnson, which deftly handled the Tylenol crisis, botching it?

To read the full story, log in.
Become a Ragan Insider member to read this article and all other archived content.
Sign up today

Already a member? Log in here.
Learn more about Ragan Insider.